Aneurysm – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Aneurysm – Drugs In Development, 2024 report and make more profitable business decisions.
An aneurysm is a weak or expanded bulge in the wall of an artery. The different types are abdominal aortic aneurysm (AAA), cerebral aneurysms, thoracic aortic aneurysm, and carotid, popliteal, mesenteric, and splenic aneurisms. Atherosclerosis, family history of aneurysm, high blood pressure, and injury to the aorta can be the causative parameters. Symptoms include lightheadedness; tachycardia; sudden, severe pain in the head, chest or back; and sudden loss of consciousness following a severe headache. CT scan, CT or MRI angiography, and ultrasound are used for diagnosis. Endovascular aneurysm repair (EVAR), open surgery, endovascular coiling, microvascular clipping, and catheter embolization are used as treatment options.
The Aneurysm drugs in development market research report provide comprehensive information on the therapeutics under development for Aneurysm, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Aneurysm and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Aneurysm | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 8 molecules, with 5 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Aneurysm therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Aneurysm pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Aneurysm treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Acasti Pharma IncGrand Pharmaceutical Group Ltd
Palo Alto Veterans Institute for Research
Serene LLC
Spanish National Research Council
Spherium Biomed SL
Tiara Pharmaceuticals Inc
University of Kentucky
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Aneurysm reports